Aristotle Capital Management LLC Sells 44,075 Shares of Roche Holding AG $RHHBY

Aristotle Capital Management LLC cut its position in shares of Roche Holding AG (OTCMKTS:RHHBY) by 2.1% during the 1st quarter, HoldingsChannel reports. The firm owned 2,063,885 shares of the company’s stock after selling 44,075 shares during the period. Aristotle Capital Management LLC’s holdings in Roche were worth $102,124,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in RHHBY. Oakworth Capital Inc. grew its position in shares of Roche by 20.8% in the 4th quarter. Oakworth Capital Inc. now owns 1,658 shares of the company’s stock worth $86,000 after buying an additional 285 shares during the period. Atlas Capital Advisors Inc. purchased a new position in shares of Roche during the fourth quarter valued at approximately $192,000. Albert D Mason Inc. bought a new stake in shares of Roche in the 4th quarter worth approximately $207,000. Pinnacle Wealth Management Advisory Group LLC bought a new position in Roche during the 1st quarter valued at approximately $208,000. Finally, Enterprise Financial Services Corp purchased a new position in Roche during the fourth quarter valued at $270,000.

Analysts Set New Price Targets

A number of research firms have recently commented on RHHBY. Argus raised Roche from a “hold” rating to a “buy” rating in a research note on Monday, April 6th. HSBC cut shares of Roche from a “buy” rating to a “hold” rating in a research note on Monday, July 6th. Zacks Research lowered shares of Roche from a “hold” rating to a “strong sell” rating in a research note on Tuesday, July 14th. Finally, Morgan Stanley raised shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 target price for the company in a report on Friday, April 24th. Four analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Roche currently has a consensus rating of “Hold” and an average price target of $51.50.

Roche Stock Up 1.4%

RHHBY stock opened at $54.70 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.12 and a current ratio of 1.38. Roche Holding AG has a 1 year low of $37.51 and a 1 year high of $60.85. The stock’s fifty day moving average price is $51.48 and its 200-day moving average price is $52.71.

Roche Company Profile

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.